Mangoceuticals regains Nasdaq minimum bid price compliance after reverse stock split

MANGOCEUTICALS, INC.

Received Nasdaq letter on Oct 30, 2024 confirming full compliance with Minimum Bid Price Requirement.
1-for-15 reverse stock split effective Oct 16, 2024 helped meet the $1.00 bid price threshold.
Nasdaq determined closing bid price was at or above $1.00 for 10 consecutive business days.
Compliance matter is now closed, removing delisting risk from Nasdaq Capital Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.